ATE403152T1 - Test zum direkten nachweisen einer biologischen zelle in einer körperflüssigkeitsprobe - Google Patents

Test zum direkten nachweisen einer biologischen zelle in einer körperflüssigkeitsprobe

Info

Publication number
ATE403152T1
ATE403152T1 AT01976048T AT01976048T ATE403152T1 AT E403152 T1 ATE403152 T1 AT E403152T1 AT 01976048 T AT01976048 T AT 01976048T AT 01976048 T AT01976048 T AT 01976048T AT E403152 T1 ATE403152 T1 AT E403152T1
Authority
AT
Austria
Prior art keywords
epitope
protein
parent
sequences
parent protein
Prior art date
Application number
AT01976048T
Other languages
English (en)
Inventor
Michael Lassen
Morten Breindahl
Original Assignee
Besst Test Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Besst Test Aps filed Critical Besst Test Aps
Application granted granted Critical
Publication of ATE403152T1 publication Critical patent/ATE403152T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Eye Examination Apparatus (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT01976048T 2000-10-17 2001-10-12 Test zum direkten nachweisen einer biologischen zelle in einer körperflüssigkeitsprobe ATE403152T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200001546 2000-10-17
US24213500P 2000-10-23 2000-10-23

Publications (1)

Publication Number Publication Date
ATE403152T1 true ATE403152T1 (de) 2008-08-15

Family

ID=8159792

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01976048T ATE403152T1 (de) 2000-10-17 2001-10-12 Test zum direkten nachweisen einer biologischen zelle in einer körperflüssigkeitsprobe

Country Status (6)

Country Link
EP (2) EP1340085B1 (de)
AT (1) ATE403152T1 (de)
AU (1) AU2002210394A1 (de)
CA (1) CA2425380A1 (de)
DK (1) DK1340085T3 (de)
WO (1) WO2002032947A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20181319T4 (hr) 2007-03-30 2024-02-16 The Research Foundation Of The State University Of New York Oslabljeni virusi koji su korisni kao cjepiva
DE102008028295A1 (de) * 2008-06-13 2009-12-17 Engler, Jörg Mittel zur direkten Detektion von Borrelia bugdorferi sensu lato in Arthropoden vor Ort (ohne Labor)
AU2015226930B2 (en) 2014-03-07 2019-12-05 The Regents Of The University Of California Devices for integrating analyte extraction, concentration and detection
WO2017041030A1 (en) 2015-09-04 2017-03-09 The Regents Of The University Of California Methods and devices for analyte collection, extraction, concentration, and detection for clinical applications
KR102592388B1 (ko) 2016-06-09 2023-10-20 더 리전트 오브 더 유니버시티 오브 캘리포니아 종이-기반 면역검정법에서 사용하기 위한 바이오마커 농축 및 신호 증폭, 그리고 dna의 추출, 농축 및 증폭을 위한 단일 플랫폼
WO2018039139A1 (en) 2016-08-22 2018-03-01 The Regents Of The University Of California Hydrogel platform for aqueous two-phase concentration of a target to enhance its detection
WO2018183211A1 (en) 2017-03-27 2018-10-04 The Regents Of The University Of California Semi-quantitative lateral-flow immunoassay for the detection of csf leaks
CN116121103B (zh) * 2022-09-16 2024-09-27 中国烟草总公司郑州烟草研究院 一株解淀粉芽孢杆菌及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1062341T3 (da) * 1998-03-16 2008-11-03 Alk Abello As Muterede rekombinante allergener
ATE390441T1 (de) * 1998-10-30 2008-04-15 Novozymes As Niedrigallergene proteinvarianten
US20020009452A1 (en) * 1999-02-10 2002-01-24 Michael Caplan Method for altering undesirable immune responses to polypeptides
AU3717600A (en) * 1999-03-02 2000-09-21 Board Of Trustees Of The University Of Arkansas, The Methods and reagents for decreasing clinical reaction to allergy

Also Published As

Publication number Publication date
DK1340085T3 (da) 2008-12-01
WO2002032947A1 (en) 2002-04-25
EP1340085B1 (de) 2008-07-30
EP1328544A1 (de) 2003-07-23
EP1340085A1 (de) 2003-09-03
AU2002210394A1 (en) 2002-04-29
CA2425380A1 (en) 2002-04-25

Similar Documents

Publication Publication Date Title
WO2000026230A8 (en) Low allergenic protein variants
ATE547528T1 (de) Eine neue gruppe von alpha-amylasen sowie ein verfahren zur identifizierung und gewinnung neuer alpha-amylasen
PL415463A1 (pl) Wyizolowany kwas nukleinowy, ssaczy wektor ekspresyjny, fuzje polipeptydowe, komórki gospodarza, sposób wytwarzania fuzji polipeptydowych, sposoby in vitro i ex vivo modyfikowania profilu glikozylacji, wyizolowana cząsteczka kwasu nukleinowego
WO2006124644A3 (en) Protein and antibody profiling using small molecule microarrays
ATE393237T1 (de) Mittel und verfahren zur in-vitro-bestimmung von camp
SE9500023D0 (sv) Method of detecting cancer
ATE403152T1 (de) Test zum direkten nachweisen einer biologischen zelle in einer körperflüssigkeitsprobe
DE602004028724D1 (de) Verfahren zur herstellung sezernierter polypeptide
WO2006126068A3 (en) Recombinant method for the production of a monoclonal antibody to cd52 for the treatment of chronic lymphocytic leukemia
ATE498013T1 (de) Für zellzyklusproteine kodierende nukleinsäure und deren verwendung
Hedhammar et al. A novel flow cytometry-based method for analysis of expression levels in Escherichia coli, giving information about precipitated and soluble protein
ATE320484T1 (de) Histone-deacetylase-8 proteine, nukleinsäuren und methoden zur verwendung
ATE474922T1 (de) Fluoreszenzproteine aus copepoda-spezies und verfahren zur verwendung davon
Groscurth et al. Artificial forisomes are ideal models of forisome assembly and activity that allow the development of technical devices
WO2002029057A3 (en) 32144, a human fatty acid amide hydrolase and uses thereof
ATE377087T1 (de) Verfahren zur herstellung eines rekombinanten rinderadenovirus-vektors
ATE321854T1 (de) Hypophysentumor verursachende gene und verwandte produkte
DE50007565D1 (de) Verfahren zum transfer von molekularen substanzen mit prokaryontischen nukleinsaure-bindenden proteinen
WO1998054212A3 (de) Das protein des humanen ryanodinrezeptors vom typ 3 sowie dafür kodierende dna-moleküle
CN107142273A (zh) 一种利用磁感应蛋白作为纯化标签实现外源蛋白一步纯化与固定化的方法，应用及通用载体
DE50014875D1 (de) Verfahren zum herstellen eines rekombinanten proteins
WO2001030987A3 (en) Tankyrase h, compositions involved in the cell cycle and methods of use
Nakai et al. Sequence‐specific cleavage of RNA by a hybrid ribonuclease H
DE60018605D1 (de) Ing2, ein mit iaps assoziiertes zellzyklusprotein, sowie zusammensetzungen, verfahren und verwendungen
WO2001036474A3 (en) Srik a novel cell cycle protein associated with rip3

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties